Inventor · disambiguated record
X. Liao
Also filed as: LIAO X C · LIAO X CHARLENE
6 granted patents·11 pending applications·10 citations·filing 2001–2025
75Inventor score
Files withRIGEL PHARMACEUTICALS INC9UNIV TEXAS3IMMUNE ONC THERAPEUTICS INC2GENENTECH INC1LORENS JAMES1
Top patents by PatentIndex Score
17 records- 0185US12202895B2LILRB4 antibodies and uses thereofUNIV TEXAS·Filed 2019·Granted Jan 21, 2025·2 cites·42 claims
- 0277US7056687B2Methods and compositions for screening for altered cellular phenotypesRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Jun 6, 2006·4 cites·59 claims
- 0372US7118854B2PAK2: modulators of lymphocyte activationRIGEL PHARMACEUTICALS INC·Filed 2001·Granted Oct 10, 2006·3 cites·12 claims
- 0468US11377491B2Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancerUNIV TEXAS·Filed 2018·Granted Jul 5, 2022·1 cites·10 claims
- 0567US2025250336A1Novel lilrb4 antibodies and uses thereofUNIV TEXAS·Filed 2025·Application pending·0 cites
- 0651US7521192B2EDG: modulators of lymphocyte activation and migrationRIGEL PHARMACEUTICALS INC·Filed 2001·Granted Apr 21, 2009·0 cites·23 claims
- 0751US2007003970A1PAK 2: modulators of lymphocyte activationRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 0850US2006147978A1Methods and compositions for screening for altered cellular phenotypesLORENS JAMES·Filed 2006·Application pending·0 cites
- 0949US2008260719A1EDG: Modulators of lymphocyte activation and migrationRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1048US2025179173A1Combination therapy of lilrb antagonist and pd-1/pd-l1 axis inhibitorIMMUNE ONC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1143US7368257B2Modulators of lymphocyte activation, Mkk3b compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2002·Granted May 6, 2008·0 cites·10 claims
- 1242US2024002503A1Novel anti-lilrb2 antibodies and derivative productsIMMUNE ONC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1341US2005130117A1Modulators of lymphocyte activation and migrationFiled 2002·Application pending·0 cites
- 1440US2002146747A1TRAC1: modulators of lymphocyte activationRIGEL PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 1540US2003109440A1GRB7: novel regulator of lymphocyte signalingRIGEL PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1639US2003013107A1Alpha 2 integrin: modulators of lymphocyte activationRIGEL PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1737US2013243750A1Anti-ige antibodies and methods using sameGENENTECH INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when X. Liao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →